Skip to content

Self-Management for Persistent Subacromial Pain

Adherence to Self-managed Exercises for Patients With Persistent Subacromial Pain: A Feasibility Study for the Ad-Shoulder Trial

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04190836
Enrollment
11
Registered
2019-12-09
Start date
2017-11-01
Completion date
2018-09-12
Last updated
2019-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain Chronic

Keywords

Shoulder pain, Persistent pain, Self-management, Exercise

Brief summary

Physiotherapy-led exercises is the first line treatment for patients with subacromial pain. However, current evidence report that most treatment programmes only show a short-term benefit. There seem to be a potential for enhancing the effectiveness of exercise interventions by improving adherence to self-managed exercises, but there is lack of knowledge about adherence to exercise programmes in shoulder pain. Before conducting a planned randomised controlled trial on the clinical effectiveness of an intervention focusing on adherence to a self-managed exercise strategy (the Ad-Shoulder intervention), it is necessary to run a feasibility study in order to establish whether such a resource-demanding trial is worthwhile. Feasibility studies are designed to answer the key question Can it work? The main objectives of the present study was to assess the feasibility in terms of recruitment capability, data collection procedures and acceptability of the Ad-Shoulder intervention in patients with subacromial pain receiving treatment in primary or secondary health care.

Interventions

BEHAVIORALSelf-Managed Exercise Strategy

The intervention is a personalised supported self-management intervention which emphasises dynamic, progressively loaded exercises for the shoulder. The intervention consisted of 1-5 individual sessions provided over 3 months, with a duration of 1 hour for the first session and 45 minutes for the following. The participants will have the opportunity to contact the physiotherapist by phone, text message or e-mail for advice during the treatment period (12 weeks). The personalised supported self-management intervention will be based on the components of the self-management framework, provided by Lorig and Holman (2003). The five self-management skills and the operationalization of these will be described when publishing the study. For specific content reporting of the self managed exercises we will follow the Consensus on Exercise Reporting Template.

Sponsors

Oslo University Hospital
CollaboratorOTHER
Keele University
CollaboratorOTHER
National Institute of Occupational Health
CollaboratorUNKNOWN
Diakonhjemmet Hospital
CollaboratorOTHER
Oslo Metropolitan University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pain located to the upper arm * Had previously received conservative treatment due to subacromial pain * Still seek primary or secondary care during the past 6 months

Exclusion criteria

* Frozen shoulder diagnosis (\<50% external rotation compared to contralateral side) * Patients who have received surgical treatment due to shoulder problems * Pregnant patients * Patients with insufficient Norwegian language skills * Serious psychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rate3 monthsHow many people that were eligible and how many people that were recruited per week
Follow-up rate3 monthsDetermine the follow-up rate - measured by the percentage of participants who were followed up successfully until the three months follow-up
Actigraph assessment of physical activity3 monthsFeasibility of Actigraph assessment of physical activity - measured by percentage of participants with valid data at Week 0, Week 6 and 3 months
Adherence3 monthsDetermine whether the patients adhere with the self-managed exercises - measured by self-reported exercise log book
Fidelity3 monthsDetermine whether the therapists delivered the intervention as planned - measured by assessing the therapists' log book
Adverse events3 monthsDetermine number and nature of adverse events via self-report questionnaire

Secondary

MeasureTime frameDescription
EQ-5D-5L3 monthsGeneric health-related quality of life will be assessed by the EQ-5D. It evaluates 5 dimensions: mobility, self-care, activities of daily living, pain, and anxiety and/or depression. For each dimension the patient describes three possible levels of problems (none, mild-to-moderate, and severe).
Global Perceived Effect scale (GPE)3 monthsThe patient rated perception of change at the follow-ups will be assessed on a Global Perceived Effect scale (GPE) at follow-up (52). The response alternatives were: 1 = completely recovered, 2 = much improved, 3 = slightly improved, 4 = no change, 5 = slightly worse, 6 = much worse, and 7 = worse than ever.
Bergen Insomnia Scale3 monthsPain-interference with sleep will be assessed by the Bergen Insomnia Scale, which consists of six items. Scoring 3 or above on at least one of the first four items and scoring 3 or above on at least one of the last two items indicate the presence of insomnia.
Shoulder pain and disability index (SPADI)3 monthsSPADI is a self-reported questionnaire for patients with shoulder pain. The questionnaire consists of 13 questions divided into two domains: pain (five items) and function (eight items) and scored on a numerical scale 0 (best) to 10 (worst) with a score range from 0 to 100 points
Physical activity (self-reported)3 monthsPhysical activity will be assessed by the 3 questions from the Nord-Trondelag Health Study (HUNT) regarding frequency, intensity and duration.
Physical activity (accelerometer)3 monthsTo objectively measure physical activity an accelerometer (AX3, 3-axis Logging Accelerometer) was used. This accelerometer provides information about movement and will enable us to objectively measure the amount of general physical activity (minutes of moderate activity). The patients will be measured for three consecutive days at baseline, at 6 weeks and at 3 months to assess changes between the three time points (Week 0, Week 6 and 3 months.
Kinesiophobia3 monthsKinesiophobia will be assessed using one question: How much 'fear' do you have that these complaints would be increased by physical activity? (scores range from 0 = no fear, to 10 = very much fear).
Patient Specific Function Scale (PSFS)3 monthsPSFS is a patient specific outcome measure where the patient is asked to name three activities which the patient find challenging or are not able to do because of their shoulder pain. Patients rate their ability to complete the activities on a 11-point scale at a level experienced prior to injury or change in functional status. 0 represents unable to perform and 10 represents able to perform at prior level.
Numeric Pain Rating Scale (NPRS)3 monthsPain intensity during the last week was measured using the NPRS (ranging from 0 = no pain, 10 = the most intense pain imaginable). Repeated measures: During a one week pre-treatment phase (A), 3 times. During the 12 week treatment phase (B): collected twice every week. During a one week post-treatment phase (A): 3 times
Pain self-efficacy 2-item short form (PSEQ-2 item)3 monthsMeasured using a 2-item questionnaire by asking the patients' how confident they are doing some form of work and to live a normal lifestyle at present, despite the pain (ranging from 0 = not at all confident, 6 = completely confident). Repeated measures: During a one week pre-treatment phase (A), 3 times. During the 12 week treatment phase (B): collected twice every week. During a one week post-treatment phase (A): 3 times
Self-efficacy3 monthsMeasured using one modified question from the Musculoskeletal Health Questionnaire: How confident have you felt about managing your shoulder pain by yourself (responses were not at all confident, slightly, moderately, very and extremely)? Repeated measures: During a one week pre-treatment phase (A), 3 times. During the 12 week treatment phase (B): collected twice every week. During a one week post-treatment phase (A): 3 times
Working Ability Index3 monthsWork ability will be measured on a 11-point scale (0 = Can not work at all, 10 = working ability is best right now)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026